A listing of recent selected publications appears below. For a comprehensive list of Dr. Waller's publications, visit PubMed or ResearchGate.

    Indoles derived from intestinal microbiota act via type I interferon signaling to limit Graft-versus-Host-Disease.
    Swimm A, Giver CR, DeFilipp Z, Rangaraju S, Sharma A, Ulezko Antonova A, Sonowal R, Capaldo C, Powell D, Qayed M, Kalman D, Waller EK.
    Blood. 2018 Sep 26. pii: blood-2018-03-838193. doi: 10.1182/blood-2018-03-838193. [Epub ahead of print]

    Improving T-cell expansion and function for adoptive T-cell therapy using ex vivo treatment with PI3Kδ inhibitors and VIP antagonists.
    Petersen CT, Hassan M, Morris AB, Jeffery J, Lee K, Jagirdar N, Staton AD, Raikar SS, Spencer HT, Sulchek T, Flowers CR, Waller EK.
    Blood Adv. 2018 Feb 13;2(3):210-223.

    Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
    Hosoba S, Waller EK, Shenvi N, Graiser M, Easley KA, Al-Kadhimi Z, Andoh A, Antun AG, Barclay S, Josephson CD, Koff JL, Khoury HJ, Langston AA, Zimring JC, Roback JD, Giver CR.
    Biol Blood Marrow Transplant. 2018 May;24(5):973-982.

    Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity.
    Forghani P, Petersen CT, Waller EK.
    Oncotarget. 2017 Sep 7;8(47):81873-81879.

    PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
    Hossain MS, Kunter GM, El-Najjar VF, Jaye DL, Al-Kadhimi Z, Taofeek OK, Li JM, Waller EK.
    PLoS One. 2017 Sep 27;12(9):e0184254.

    Administration of a vasoactive intestinal peptide antagonist enhances the autologous anti-leukemia T cell response in murine models of acute leukemia.
    Petersen CT, Li JM, Waller EK.
    Oncoimmunology. 2017 Mar 16;6(5):e1304336.

    Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.
    Li JM, Petersen CT, Li JX, Panjwani R, Chandra DJ, Giver CR, Blazar BR, Waller EK.
    Cancer Res. 2016 Dec 1;76(23):6802-6815.

    Chemokine and lymph node homing receptor expression on pDC vary by graft source.
    Hosoba S, Harris WA, Lin KL, Waller EK.
    Oncoimmunology. 2014 Dec 15;3(10):e958957.

    GVHD clears the Aire in thymic selection.
    Hassan MN, Waller EK.
    Blood. 2015 Apr 23;125(17):2593-5

    Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.
    Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C.
    J Clin Oncol. 2014 Aug 1;32(22):2365-72.

    Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice.
    Hossain MS, Ramachandiran S, Gewirtz AT, Waller EK.
    PLoS One. 2014 May 30;9(5):e96165.

    Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation.
    Darlak KA, Wang Y, Li JM, Harris WA, Owens LM, Waller EK.
    Biol Blood Marrow Transplant. 2013 Sep;19(9):1331-9.

    VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.
    Li JM, Darlak KA, Southerland L, Hossain MS, Jaye DL, Josephson CD, Rosenthal H, Waller EK.
    PLoS One. 2013 May 27;8(5):e63381.

    Pharmacological inhibition of VIP signaling enhances antiviral immunity and improves survival in murine cytomegalovirus-infected allogeneic bone marrow transplant recipients.
    Li JM, Hossain MS, Southerland L, Waller EK.
    Blood. 2013 Mar 21;121(12):2347-51.

    IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
    Lu Y, Giver CR, Sharma A, Li JM, Darlak KA, Owens LM, Roback JD, Galipeau J, Waller EK.
    Blood. 2012 Jan 26;119(4):1075-85.